Marshall Wace North America’s Repligen RGEN Stock Holding History

Marshall Wace North America’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$40M	Buy	138,431 +137,336	+12,542%	+$35.2M	0.17%	134
2021 Q2	$219K	Sell	1,095 -150,149	-99%	-$29.1M	﹤0.01%	1334
2021 Q1	$29.4M	Sell	151,244 -102,099	-40%	-$20.9M	0.12%	194
2020 Q4	$48.5M	Buy	+253,343	New	+$46.1M	0.22%	121
2020 Q3	–	Sell	-2,924	Closed	-$361K	–	1431
2020 Q2	$361K	Buy	+2,924	New	+$344K	﹤0.01%	977
2019 Q1	–	Sell	-3,186	Closed	-$168K	–	1846
2018 Q4	$168K	Buy	+3,186	New	+$187K	﹤0.01%	988
2018 Q1	–	Sell	-139,121	Closed	-$5.05M	–	1657
2017 Q4	$5.05M	Buy	139,121 +43,215	+45%	+$1.56M	0.03%	575
2017 Q3	$3.64M	Sell	95,906 -318,240	-77%	-$13.3M	0.02%	636
2017 Q2	$17M	Buy	414,146 +156,828	+61%	+$5.96M	0.12%	211
2017 Q1	$9.01M	Buy	+257,318	New	+$8.15M	0.07%	290

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace North America's RGEN Position: Q3 2021 in Review

Marshall Wace North America increased its Repligen (RGEN) stake by 12,542% in Q3 2021, buying an estimated $35.2M and bringing the position to 138,431 shares worth $40M. The position accounts for 0.17% of the portfolio, ranked #134.

Marshall Wace North America first reported a position in RGEN in Q1 2017 and has held it in 10 quarters since. The position peaked at $48.5M in Q4 2020. 479 funds tracked by Wall St. Rank hold RGEN as of Q3 2021.

Marshall Wace North America held 138,431 shares of Repligen worth $40M as of Q3 2021.
Marshall Wace North America bought 137,336 Repligen shares in Q3 2021, an estimated $35.2M.
Repligen made up 0.17% of Marshall Wace North America's portfolio in Q3 2021, its #134 holding.
Marshall Wace North America first reported a position in Repligen in Q1 2017 and has held it in 10 quarters since.
Marshall Wace North America's Repligen position peaked at $48.5M in Q4 2020.
479 funds tracked by Wall St. Rank held Repligen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.